Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates. |
Low AJ, Dong WW, Chan D, Sing T, Swanstrom R, Jensen M, Pillai S, Good B, Harrigan PR |
2007 |
Foscarnet used in salvage therapy of HIV-1 patients harbouring multiple nucleotide excision mutations. |
Mathiesen S, Roge BT, Weis N, Lundgren JD, Obel N, Gerstoft J |
2004 |
A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RT. |
White KL, Margot NA, Ly JK, Chen JM, Ray AS, Pavelko M, Wang R, McDermott MJ, Swaminathan S, Miller MD |
2005 |
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group. |
Pellegrin I, Izopet J, Reynes J, Denayrolles M, Montes B, Pellegrin JL, Massip P, Puel J, Fleury H, Segondy M |
1999 |
Stable rearrangements of the beta3-beta4 hairpin loop of HIV-1 reverse transcriptase in plasma viruses from patients receiving combination therapy. |
Tamalet C, Izopet J, Koch N, Fantini J, Yahi N |
1998 |
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs. |
de Jong JJ, Goudsmit J, Lukashov VV, Hillebrand ME, Baan E, Huismans R, Danner SA, ten Veen JH, de Wolf F, Jurriaans S |
1999 |
Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine. |
Coakley EP, Gillis JM, Hammer SM |
2000 |
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. |
Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, Montaner JS |
2007 |
HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy. |
Miller V, Ait-Khaled M, Stone C, Griffin P, Mesogiti D, Cutrell A, Harrigan R, Staszewski S, Katlama C, Pearce G, Tisdale M |
2000 |
Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients. |
Phillips EJ, GutiƩrrez S, Jahnke N, Yip B, Lima VD, Hogg RS, Harrigan PR, Montaner JS |
2007 |